Literature DB >> 10873399

Better treatments that cost more: the dilemma.

L Elit, A Gafni, M N Levine.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2000        PMID: 10873399     DOI: 10.1006/gyno.2000.5885

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  1 in total

1.  Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Authors:  Raymond J Osborne; Virginia Filiaci; Julian C Schink; Robert S Mannel; Angeles Alvarez Secord; Joseph L Kelley; Diane Provencher; David Scott Miller; Allan L Covens; Janice M Lage
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.